Drug General Information
Drug ID
D00BVS
Former ID
DNCL002726
Drug Name
Tanezumab
Drug Type
Monoclonal antibody
Indication Cancer pain [ICD9: 140-229, 338,780; ICD10:R52, G89] Phase 3 [522522], [543119]
Company
Pfizer New York, NY
CAS Number
CAS 880266-57-9
References
Ref 522522ClinicalTrials.gov (NCT00809783) Extension Study Of Tanezumab In Osteoarthritis. U.S. National Institutes of Health.
Ref 543119(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8415).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.